Table 3.

Association of candidates with clinicopathological characteristics.

	HSPA1A		CD99		RAB3A		POM121L9P
	OR	95% CI	OR	95% CI	OR	95% CI	OR	95% CI
Tumour stage	1.78	1.10–2.99	8.66	0.51–1.43	3.63	1.56–9.15	0.85	0.50–1.45
Tumour grade	3.84	2.03–7.9	5.68	0.30–1.02	3.93	1.44–11.76	0.80	0.42–1.57
Disease progression	2.12	1.28–3.65	1.52	0.89–2.70	4.04	1.66–10.59	1.14	0.64–2.08
Chemotherapy resistance	1.20	0.71–2.07	4.78	2.23–11.22	4.61	1.87–12.23	1.22	0.69–2.23
Menopause	1.03	0.62–1.70	0.98	0.57–1.76	0.61	0.24–1.45	0.81	0.43–1.41

OR odds ratio, CI confidence interval.